A Population-Based Study of Anterior Ischemic Optic Neuropathy Following Cataract Surgery.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
02 2021
Historique:
received: 17 06 2020
revised: 08 08 2020
accepted: 08 08 2020
pubmed: 21 8 2020
medline: 17 3 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

To determine if there is an increased incidence rate of post-cataract surgery (pcs) anterior ischemic optic neuropathy (AION) compared to spontaneous AION (sAION). Retrospective, population-based cohort. Patients diagnosed with AION from January 1, 1990, through December 31, 2016, while residing in Olmsted County, Minnesota. Patients with cataract surgery preceding AION were included in the pcsAION cohort defined in 2 ways: AION within 2 months and AION within 1 year of cataract surgery. The incidence rates of pcsAION and sAION were compared using Poisson regression models. During the study period, 102 residents developed AION. The median age was 65 years (range, 40-90 years), 44 (43.1%) were female. Twenty of 102 (19.6%) patients had previous cataract surgery, of which 2 and 9 developed AION within 2 months and 1 year of surgery, respectively. The annual incidence rate of pcsAION within 2 months of surgery (8.6 per 100,000) was not significantly greater than the annual incidence rate of sAION (6.9 per 100,000; P = .78). However, the annual incidence rate of pcsAION within 1 year of surgery (38.9 per 100,000) was significantly higher than the incidence rate of sAION (6.5 per 100,000; P < .001). The incidence of AION is increased in the first year after cataract surgery, but not in the early (i.e., 2 months) postoperative period.

Identifiants

pubmed: 32818451
pii: S0002-9394(20)30446-3
doi: 10.1016/j.ajo.2020.08.020
pmc: PMC7889757
mid: NIHMS1622812
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-165

Subventions

Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG058738
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Br J Ophthalmol. 2007 May;91(5):585-7
pubmed: 17446504
Arch Ophthalmol. 1997 Nov;115(11):1441-6
pubmed: 9366677
Am J Ophthalmol. 2003 Dec;136(6):1171-2
pubmed: 14644238
J Neuroophthalmol. 2005 Mar;25(1):22-4
pubmed: 15756128
Am J Ophthalmol. 2001 Sep;132(3):408-9
pubmed: 11530058
Mayo Clin Proc. 2012 Dec;87(12):1202-13
pubmed: 23199802
J Cataract Refract Surg. 2006 Dec;32(12):2105-9
pubmed: 17137991
Korean J Ophthalmol. 2010 Feb;24(1):57-61
pubmed: 20157417
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Int Ophthalmol Clin. 2010 Winter;50(1):139-53
pubmed: 20057303
Ophthalmology. 2001 Jul;108(7):1275-8
pubmed: 11425687
J Cataract Refract Surg. 2007 Jul;33(7):1273-7
pubmed: 17586386
Pan Afr Med J. 2017 Sep 21;28:53
pubmed: 29184605
Arq Bras Oftalmol. 2007 May-Jun;70(3):544-6
pubmed: 17768569
Ann Ophthalmol. 1973 Mar;5(3):303-6
pubmed: 4694915
Am J Ophthalmol. 2019 Nov;207:343-350
pubmed: 31415735
Am J Ophthalmol. 2017 Mar;175:183-193
pubmed: 27984025
Am J Ophthalmol. 2017 Mar;175:xiv-xvi
pubmed: 28108001
J Cataract Refract Surg. 2020 Jul;46(7):1056-1057
pubmed: 32773551
J Am Intraocul Implant Soc. 1982 Spring;8(2):144-7
pubmed: 7130020
Arch Ophthalmol. 1980 Aug;98(8):1410-6
pubmed: 7417076
Arch Ophthalmol. 1982 Jul;100(7):1177-8
pubmed: 7092663
Am J Ophthalmol. 1997 Jan;123(1):103-7
pubmed: 9186104
Br J Ophthalmol. 2007 May;91(5):563
pubmed: 17446500

Auteurs

Sasha A Mansukhani (SA)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

John J Chen (JJ)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Aaron M Fairbanks (AM)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Robert C Foster (RC)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Jay C Erie (JC)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Keith H Baratz (KH)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

David O Hodge (DO)

Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.

M Tariq Bhatti (MT)

Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. Electronic address: bhatti.muhammad@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH